Skip to main content
SP5007,718.35+0.56%DOW53,549.55+0.16%NASDAQ26,453.06+1.24%BTC$79,970.00+2.02%ETH$2,496.66+1.32%GOLD$4,655.20+0.04%OIL$83.59+1.65%
Smart Investors Daily
Sign InSign Up Free
CB

OTC · CBSC

Cardiac Biotech Solutions Inc.

Healthcare · Medical - Instruments & Supplies

$0.04

Up+$0.00 (+0.00%)

Updated Aug 27, 2026, 6:43 PM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
2.83M
P/E ratio
-2.55
Dividend yield
0.00%
52-week range
— – —
Volume
300
Avg. volume
22.91K

Price performance

CBSC price history

1M range · 0 trading sessions · Daily adjusted prices

CBSC does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest CBSC news

The latest Smart Investors Daily articles mentioning CBSC.

Stock researchCompany · Overview

CBSC research

Overview

Company profile and research snapshot.

Company profile

CARDIAC BIOTECH SOLUTION

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 15, 2026

Cardiac Biotech Solutions Activates China Production Pipeline for MyCardia AT and Moves into Final NMPA Submission Phase

Regulated manufacturing, hospital field trials, and regulatory filings now underway with Ebulent Medical in ShenzhenLAS VEGAS, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cardiac Biotech Solutions, Inc. (OTCID: CBSC) (“CBSC” or the “Company”), a designer, manufacturer and distributor of non-invasive ambulatory cardiac monitoring products, today provided an update on the execution of its China market entry plan for its MyCardia AT cardiac event monitoring device. The Company has formally initiated manufact

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By